Expertise in Neurology Clinical Trials


Worldwide Clinical Trials takes pride in bringing a
depth of knowledge to your study based on experience in trials across a range of neurologic disorders.

Our clinical experience enables us to work with you at any stage of drug development from Phase I through Phase IV for traditional, as well as, highly innovative clinical targets.

Worldwide has participated in the design, execution, or analysis of 105 trials, over 550 sites and 2840 patients since 2008. Of the 105 total trials, 55 studies have included at least clinical monitoring or project management. A majority of these studies have been conducted globally including unique capabilities in Russia, Ukraine and Eastern Europe.

Representative capabilities for neurological disorders include the following:

  • Scale selection appropriate to culture and language including the credentialing of investigative site staff, and methods of surveillance following study initiation.
  • Specialized patient-based assessments for various neurologic disorders, particularly in proof of concept trials.
  • Utilization of novel pain questionnaires unique to medical device applications in breakthrough episodic pain and postoperative neuropathic pain.
  • In-house analytical and pharmacokinetic capabilities including novel assay development, and the transfer and validation for established analytes in various matrices.

Download this information in PDF format here.